Selected research
Industry Growth & Trends
Global Lomustine Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Lomustine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Lomustine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Lomustine is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Lomustine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Lomustine market include Zhongfu Pharma, Nanjing Pharma, Bristol-Myers Squibb, Ther Dose, NextSource Pharma, Miracalus Pharma, Medicon Pharma and ACTIZA, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Lomustine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Lomustine market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Lomustine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Lomustine.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Lomustine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Lomustine Market by Company
Zhongfu Pharma
Nanjing Pharma
Bristol-Myers Squibb
Ther Dose
NextSource Pharma
Miracalus Pharma
Medicon Pharma
ACTIZA
Lomustine Segment by Type
10mg/Tablet
40mg/Tablet
100mg/Tablet
Lomustine Segment by Application
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies
Lomustine Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Lomustine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Lomustine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Lomustine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Lomustine companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- 10mg/Tablet
- 40mg/Tablet
- 100mg/Tablet
Applications
- Hospital Pharmacies
- Online Pharmacies
- Retail Pharmacies
Companies covered
- Zhongfu Pharma
- Nanjing Pharma
- Bristol-Myers Squibb
- Ther Dose
- NextSource Pharma
- Miracalus Pharma
- Medicon Pharma
- ACTIZA
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Lomustine Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Lomustine Market Size by Region (2021-2032)
- 1.4.1 Global Lomustine Market Size by Region (2021-2026)
- 1.4.2 Global Lomustine Market Size by Region (2027-2032)
- 1.5 Key Regions Lomustine Market Size (2021-2032)
- 1.5.1 North America Lomustine Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Lomustine Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Lomustine Market Size Growth Rate (2021-2032)
- 1.5.4 South America Lomustine Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Lomustine Market Size Growth Rate (2021-2032)
2 Lomustine Market by Type
- 2.1 Type Introduction
- 2.1.1 10mg/Tablet
- 2.1.2 40mg/Tablet
- 2.1.3 100mg/Tablet
- 2.2 Global Lomustine Market Size by Type
- 2.2.1 Global Lomustine Market Size Overview by Type (2021-2032)
- 2.2.2 Global Lomustine Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Lomustine Market Size Forecasted by Type (2027-2032)
- 2.3 Global Lomustine Market Size by Regions
- 2.3.1 North America Lomustine Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Lomustine Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Lomustine Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Lomustine Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Lomustine Market Size Breakdown by Type (2021-2026)
3 Lomustine Market by Application
- 3.1 Type Introduction
- 3.1.1 Hospital Pharmacies
- 3.1.2 Online Pharmacies
- 3.1.3 Retail Pharmacies
- 3.2 Global Lomustine Market Size by Application
- 3.2.1 Global Lomustine Market Size Overview by Application (2021-2032)
- 3.2.2 Global Lomustine Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Lomustine Market Size Forecasted by Application (2027-2032)
- 3.3 Global Lomustine Market Size by Regions
- 3.3.1 North America Lomustine Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Lomustine Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Lomustine Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Lomustine Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Lomustine Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Lomustine Industry Trends
- 4.2 Lomustine Industry Drivers
- 4.3 Lomustine Industry Opportunities and Challenges
- 4.4 Lomustine Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Lomustine Revenue (2021-2026)
- 5.2 Global Lomustine Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Lomustine Key Company Headquarters & Area Served
- 5.4 Global Lomustine Company, Product Type & Application
- 5.5 Global Lomustine Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Lomustine Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Lomustine Players Market Share by Revenue in 2025
- 5.6.3 2025 Lomustine Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Zhongfu Pharma
- 6.1.1 Zhongfu Pharma Company Information
- 6.1.2 Zhongfu Pharma Business Overview
- 6.1.3 Zhongfu Pharma Lomustine Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Zhongfu Pharma Lomustine Product Portfolio
- 6.1.5 Zhongfu Pharma Recent Developments
- 6.2 Nanjing Pharma
- 6.2.1 Nanjing Pharma Company Information
- 6.2.2 Nanjing Pharma Business Overview
- 6.2.3 Nanjing Pharma Lomustine Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Nanjing Pharma Lomustine Product Portfolio
- 6.2.5 Nanjing Pharma Recent Developments
- 6.3 Bristol-Myers Squibb
- 6.3.1 Bristol-Myers Squibb Company Information
- 6.3.2 Bristol-Myers Squibb Business Overview
- 6.3.3 Bristol-Myers Squibb Lomustine Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Bristol-Myers Squibb Lomustine Product Portfolio
- 6.3.5 Bristol-Myers Squibb Recent Developments
- 6.4 Ther Dose
- 6.4.1 Ther Dose Company Information
- 6.4.2 Ther Dose Business Overview
- 6.4.3 Ther Dose Lomustine Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Ther Dose Lomustine Product Portfolio
- 6.4.5 Ther Dose Recent Developments
- 6.5 NextSource Pharma
- 6.5.1 NextSource Pharma Company Information
- 6.5.2 NextSource Pharma Business Overview
- 6.5.3 NextSource Pharma Lomustine Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 NextSource Pharma Lomustine Product Portfolio
- 6.5.5 NextSource Pharma Recent Developments
- 6.6 Miracalus Pharma
- 6.6.1 Miracalus Pharma Company Information
- 6.6.2 Miracalus Pharma Business Overview
- 6.6.3 Miracalus Pharma Lomustine Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Miracalus Pharma Lomustine Product Portfolio
- 6.6.5 Miracalus Pharma Recent Developments
- 6.7 Medicon Pharma
- 6.7.1 Medicon Pharma Company Information
- 6.7.2 Medicon Pharma Business Overview
- 6.7.3 Medicon Pharma Lomustine Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 Medicon Pharma Lomustine Product Portfolio
- 6.7.5 Medicon Pharma Recent Developments
- 6.8 ACTIZA
- 6.8.1 ACTIZA Company Information
- 6.8.2 ACTIZA Business Overview
- 6.8.3 ACTIZA Lomustine Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 ACTIZA Lomustine Product Portfolio
- 6.8.5 ACTIZA Recent Developments
7 North America
- 7.1 North America Lomustine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Lomustine Market Size by Country (2021-2026)
- 7.3 North America Lomustine Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Lomustine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Lomustine Market Size by Country (2021-2026)
- 8.3 Europe Lomustine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Lomustine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Lomustine Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Lomustine Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Lomustine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Lomustine Market Size by Country (2021-2026)
- 10.3 South America Lomustine Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Lomustine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Lomustine Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Lomustine Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst